{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T12:07:58Z","timestamp":1763381278311,"version":"3.45.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T00:00:00Z","timestamp":1758240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T00:00:00Z","timestamp":1758240000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R01AG071514","R56AG074889","U01AG084528","R01AG071643","R01AG078214"],"award-info":[{"award-number":["R01AG071514","R56AG074889","U01AG084528","R01AG071643","R01AG078214"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Ther"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s40120-025-00822-x","type":"journal-article","created":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T08:55:43Z","timestamp":1758272143000},"page":"2327-2344","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Testing the Clinical Dementia Rating Sum of Boxes as an Outcome for Dementia with Lewy Bodies Clinical Trials"],"prefix":"10.1007","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5678-245X","authenticated-orcid":false,"given":"James E.","family":"Galvin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andres","family":"Salcedo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,9,19]]},"reference":[{"key":"822_CR1","unstructured":"Lewy Body Dementia Association. Lewy body dementia symptoms, diagnosis, and treatment. http:\/\/www.lbda.org. Accessed 24 July 2025."},{"key":"822_CR2","first-page":"67","volume":"18","author":"JE Galvin","year":"2019","unstructured":"Galvin JE. Lewy body dementia: clinical diagnosis and management. Pract Neurol. 2019;18:67\u201371.","journal-title":"Pract Neurol"},{"key":"822_CR3","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1212\/CON.0000000000001496","volume":"30","author":"JE Galvin","year":"2024","unstructured":"Galvin JE. Lewy body dementia. Continuum. 2024;30:1673\u201398.","journal-title":"Continuum"},{"key":"822_CR4","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1212\/WNL.0000000000009323","volume":"94","author":"IG McKeith","year":"2020","unstructured":"McKeith IG, Ferman TJ, Thomas AJ, Blanc F, Boeve BF, Fujishiro H, et al. Research criteria for the diagnosis of prodromal dementia with Lewy bodies. Neurology. 2020;94:743\u201355.","journal-title":"Neurology"},{"key":"822_CR5","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1212\/WNL.0000000000004058","volume":"89","author":"IG McKeith","year":"2017","unstructured":"McKeith IG, Boeve BF, Dickson DW, Halliday G, Taylor JP, Weintraub D, et al. Diagnosis and management of dementia with Lewy bodies: fourth consensus report of the DLB Consortium. Neurology. 2017;89:88\u2013100.","journal-title":"Neurology"},{"key":"822_CR6","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.parkreldis.2010.03.007","volume":"16","author":"JE Galvin","year":"2010","unstructured":"Galvin JE, Duda JE, Kaufer DI, Lippa CF, Taylor A, Zarit SH. Lewy body dementia: the caregiver experience of clinical care. Parkinsonism Relat Disord. 2010;16:388\u201392.","journal-title":"Parkinsonism Relat Disord"},{"key":"822_CR7","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","volume":"7","author":"GM McKhann","year":"2011","unstructured":"McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR Jr, Kawas CH, et al. The diagnosis of dementia due to Alzheimer\u2019s disease: recommendations from the National Institute on Aging\u2013Alzheimer\u2019s association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimers Dement. 2011;7:263\u20139.","journal-title":"Alzheimers Dement"},{"key":"822_CR8","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/mds.26424","volume":"30","author":"RB Postuma","year":"2015","unstructured":"Postuma RB, Berg D, Stern M, Adler CH, Bloem BR, Chan P, et al. MDS clinical diagnostic criteria for Parkinson\u2019s disease. Mov Disord. 2015;30:1591\u2013601.","journal-title":"Mov Disord"},{"issue":"12","key":"822_CR9","doi-asserted-by":"publisher","first-page":"2308","DOI":"10.1212\/WNL.44.12.2308","volume":"44","author":"JL Cummings","year":"1994","unstructured":"Cummings JL, Mega M, Gray K, Rosenberg-Thompson S, Carusi DA, Gornbein J. The neuropsychiatric inventory: comprehensive assessment of psychopathology in dementia. Neurology. 1994;44(12):2308\u201314.","journal-title":"Neurology"},{"key":"822_CR10","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1002\/alz.12334","volume":"17","author":"JE Galvin","year":"2021","unstructured":"Galvin JE, Chrisphonte S, Cohen I, Greenfield KK, Kleiman MJ, Moore C, et al. Characterization of dementia with Lewy bodies (DLB) and mild cognitive impairment using the Lewy body dementia module (LBD-MOD). Alzheimers Dement. 2021;17:1675\u201386.","journal-title":"Alzheimers Dement"},{"key":"822_CR11","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1016\/S1474-4422(24)00442-3","volume":"23","author":"BF Boeve","year":"2024","unstructured":"Boeve BF, Ferman TJ. REM sleep behavior disorder and alpha-synuclein. Lancet Neurol. 2024;23:1176\u20138.","journal-title":"Lancet Neurol"},{"key":"822_CR12","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1212\/WNL.62.2.181","volume":"62","author":"TJ Ferman","year":"2004","unstructured":"Ferman TJ, Smith GE, Boeve BF, Ivnik RJ, Petersen RC, Knopman D, et al. DLB fluctuations: specific features that reliably differentiate DLB from AD and normal aging. Neurology. 2004;62:181\u20137.","journal-title":"Neurology"},{"key":"822_CR13","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1097\/WAD.0b013e318142774e","volume":"21","author":"DL Beekly","year":"2007","unstructured":"Beekly DL, Ramos EM, Lee WW, Deitrich WD, Jacka ME, Wu J. The national Alzheimer\u2019s coordinating center (NACC) database: the uniform data set. Alzheimer Dis Assoc Disord. 2007;21:249\u201358.","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"822_CR14","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1097\/WAD.0000000000000223","volume":"32","author":"S Weintraub","year":"2018","unstructured":"Weintraub S, Besser L, Dodge HH, Teylan M, Ferris S, Goldstein FC, et al. Version 3 of the Alzheimer Disease Centers\u2019 neuropsychological test battery in the Uniform Data Set (UDS). Alzheimer Dis Assoc Disord. 2018;32:10\u20137.","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"822_CR15","unstructured":"NIH Reporter. https:\/\/projectreporter.nih.gov\/reporter.cfm. Accessed 24 July 2025."},{"key":"822_CR16","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000209656","volume":"103","author":"DG Coughlin","year":"2024","unstructured":"Coughlin DG, MacLeod KR, Middleton JS, Bozoki AC, Galvin JE, Irwin DJ, et al. Association of CSF \u03b1-synuclein seeding amplification assay results with clinical features of possible and probable dementia with Lewy bodies. Neurology. 2024;103: e209656.","journal-title":"Neurology"},{"key":"822_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-020-00703-5","volume":"12","author":"JG Goldman","year":"2020","unstructured":"Goldman JG, Forsberg LK, Boeve BF, Armstrong MJ, Irwin DJ, Ferman TJ, et al. Challenges and opportunities for improving the landscape for Lewy body dementia clinical trials. Alzheimers Res Ther. 2020;12: 137.","journal-title":"Alzheimers Res Ther"},{"key":"822_CR18","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1097\/WCO.0000000000001173","volume":"36","author":"LL Gibson","year":"2023","unstructured":"Gibson LL, Abdelnour C, Chong J, Ballard C, Aarsland D. Clinical trials in dementia with Lewy bodies: the evolving concept of co-pathologies, patient selection and biomarkers. Curr Opin Neurol. 2023;36:264\u201375.","journal-title":"Curr Opin Neurol"},{"key":"822_CR19","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1007\/s40120-023-00467-8","volume":"12","author":"C Abdelnour","year":"2023","unstructured":"Abdelnour C, Gonzalez MC, Gibson LL, Poston KL, Ballard CG, Cummings JL, Aarsland D. Dementia with Lewy bodies drug therapies in clinical trials: systematic review up to 2022. Neurol Ther. 2023;12:727\u201349.","journal-title":"Neurol Ther"},{"key":"822_CR20","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1080\/14728214.2023.2244425","volume":"28","author":"MI Tolea","year":"2023","unstructured":"Tolea MI, Ezzeddine R, Camacho S, Galvin JE. Emerging drugs for dementia with Lewy bodies: a review of phase II & III trials. Expert Opin Emerg Drugs. 2023;28:167\u201380.","journal-title":"Expert Opin Emerg Drugs"},{"key":"822_CR21","doi-asserted-by":"publisher","DOI":"10.1002\/trc2.12375","volume":"9","author":"MN Sabbagh","year":"2023","unstructured":"Sabbagh MN, Taylor A, Galasko D, Galvin JE, Goldman JG, Leverenz JB, Poston KL, Boeve BF, Irwin DJ, Quinn JF. Listening session with the US Food and Drug Administration, Lewy Body Dementia Association, and an expert panel. Alzheimers Dement (N Y). 2023;9: e12375.","journal-title":"Alzheimers Dement (N Y)"},{"key":"822_CR22","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1080\/03007995.2022.2059978","volume":"38","author":"U Desai","year":"2022","unstructured":"Desai U, Chandler J, Kirson N, Georgieva M, Cheung HC, Westermeyer B, et al. Epidemiology and economic burden of Lewy body dementia in the United States. Curr Med Res Opin. 2022;38:1177\u201388.","journal-title":"Curr Med Res Opin"},{"key":"822_CR23","doi-asserted-by":"publisher","first-page":"e1320","DOI":"10.4088\/JCP.15f10377","volume":"76","author":"C Andrade","year":"2015","unstructured":"Andrade C. The primary outcome measure and its importance in clinical trials. J Clin Psychiatry. 2015;76:e1320-1323.","journal-title":"J Clin Psychiatry"},{"key":"822_CR24","unstructured":"Clinical Trials. https:\/\/clinicaltrials.gov. Accessed 24 July 2025."},{"key":"822_CR25","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s40035-022-00299-w","volume":"11","author":"F Rodriguez-Porcel","year":"2022","unstructured":"Rodriguez-Porcel F, Wyman-Chick KA, Abdelnour Ruiz C, Toledo JB, Ferreira D, Urwyler P, et al. Clinical outcome measures in dementia with Lewy body trials: critique and recommendations. Transl Neurodegener. 2022;11:24.","journal-title":"Transl Neurodegener"},{"key":"822_CR26","first-page":"66","volume":"6","author":"B Patel","year":"2021","unstructured":"Patel B, Irwin DJ, Kaufer D, Boeve BF, Taylor A, Armstrong MJ. Outcome measures for dementia with Lewy body clinical trials: a review. Alzheimer Dis Assoc Disord. 2021;6:66.","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"822_CR27","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/j.jclinepi.2010.02.006","volume":"63","author":"LB Mokkink","year":"2010","unstructured":"Mokkink LB, Terwee CB, Patrick DL, Alonso J, Stratford PW, Knol DL, et al. The COSMIN study reached international consensus on taxonomy, terminology, and definitions of measurement properties for health-related patient-reported outcomes. J Clin Epidemiol. 2010;63:737\u201345.","journal-title":"J Clin Epidemiol"},{"key":"822_CR28","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/S2215-0366(21)00197-8","volume":"8","author":"KY Liu","year":"2021","unstructured":"Liu KY, Schneider LS, Howard R. The need to show minimum clinically important differences in Alzheimer\u2019s disease trials. Lancet Psychiatry. 2021;8:1013\u20136.","journal-title":"Lancet Psychiatry"},{"issue":"Suppl 2","key":"822_CR29","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.1097\/00002093-199700112-00003","volume":"11","author":"RC Mohs","year":"1997","unstructured":"Mohs RC, Knopman D, Petersen RC, Ferris SH, Ernesto C, Grundman M, et al. Development of cognitive instruments for use in clinical trials of antidementia drugs: additions to the Alzheimer\u2019s Disease Assessment Scale that broaden its scope. The Alzheimer\u2019s Disease Cooperative Study. Alzheimer Dis Assoc Disord. 1997;11(Suppl 2):S13-21.","journal-title":"Alzheimer Dis Assoc Disord"},{"issue":"Suppl 2","key":"822_CR30","doi-asserted-by":"publisher","first-page":"S33","DOI":"10.1097\/00002093-199700112-00005","volume":"11","author":"D Galasko","year":"1997","unstructured":"Galasko D, Bennett D, Sano M, Ernesto C, Thomas R, Grundman M, et al. An inventory to assess activities of daily living for clinical trials in Alzheimer\u2019s disease. The Alzheimer\u2019s disease cooperative study. Alzheimer Dis Assoc Disord. 1997;11(Suppl 2):S33\u20139.","journal-title":"Alzheimer Dis Assoc Disord"},{"issue":"Suppl 2","key":"822_CR31","doi-asserted-by":"publisher","first-page":"S22","DOI":"10.1097\/00002093-199700112-00004","volume":"11","author":"LS Schneider","year":"1997","unstructured":"Schneider LS, Olin JT, Doody RS, Clark CM, Morris JC, Reisberg B, et al. Validity and reliability of the Alzheimer\u2019s disease cooperative study-clinical global impression of change. The Alzheimer\u2019s disease cooperative study. Alzheimer Dis Assoc Disord. 1997;11(Suppl 2):S22-32.","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"822_CR32","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1002\/mds.22340","volume":"23","author":"CG Goetz","year":"2008","unstructured":"Goetz CG, Tilley BC, Shaftman SR, Stebbins GT, Fahn S, Martinez-Martin P, et al. Movement disorder society-sponsored revision of the Unified Parkinson\u2019s Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord. 2008;23:2129\u201370.","journal-title":"Mov Disord"},{"key":"822_CR33","doi-asserted-by":"publisher","first-page":"2412","DOI":"10.1212\/WNL.43.11.2412-a","volume":"43","author":"JC Morris","year":"1993","unstructured":"Morris JC. The clinical dementia rating (CDR): current version and scoring rules. Neurology. 1993;43:2412\u20134.","journal-title":"Neurology"},{"key":"822_CR34","volume":"12","author":"LS Schneider","year":"2020","unstructured":"Schneider LS, Goldberg TE. Composite cognitive and functional measures for early stage Alzheimer\u2019s disease trials. Alzheimers Dement. 2020;12: e12017.","journal-title":"Alzheimers Dement"},{"key":"822_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.tjpad.2025.100101","volume":"12","author":"L Delbecque","year":"2025","unstructured":"Delbecque L, Elliott E, Cleanthous S, Heinrich P, Cano S, Wessels AM, Atkins AS. Qualitative research and literature review support the integrated Alzheimer\u2019s Disease Rating Scale (iADRS) content validity in early symptomatic AD. J Prev Alzheimers Dis. 2025;12: 100101.","journal-title":"J Prev Alzheimers Dis"},{"key":"822_CR36","first-page":"316","volume":"1","author":"JE Galvin","year":"2015","unstructured":"Galvin JE. Improving the clinical detection of Lewy body dementia with the Lewy Body Composite Risk Score. Alzheimers Dement. 2015;1:316\u201324.","journal-title":"Alzheimers Dement"},{"key":"822_CR37","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1002\/gps.4609","volume":"32","author":"AJ Thomas","year":"2017","unstructured":"Thomas AJ, Taylor JP, McKeith I, Bamford C, Burn D, Allan L, et al. Development of assessment toolkits for improving the diagnosis of the Lewy body dementias: feasibility study within the DIAMOND Lewy study. Int J Geriatr Psychiatry. 2017;32:1280\u2013304.","journal-title":"Int J Geriatr Psychiatry"},{"key":"822_CR38","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1093\/ptj\/80.9.896","volume":"80","author":"A Shumway-Cook","year":"2000","unstructured":"Shumway-Cook A, Brauer S, Woollacott M. Predicting the probability for falls in community-dwelling older adults using the timed up & go test. Phys Ther. 2000;80:896\u2013903.","journal-title":"Phys Ther"},{"key":"822_CR39","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.archger.2009.02.006","volume":"50","author":"CH Wilkins","year":"2010","unstructured":"Wilkins CH, Roe CM, Morris JC. A brief clinical tool to assess physical function: the mini-physical performance test. Arch Gerontol Geriatr. 2010;50:96\u2013100.","journal-title":"Arch Gerontol Geriatr"},{"key":"822_CR40","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1093\/sleep\/14.6.540","volume":"14","author":"MW Johns","year":"1991","unstructured":"Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep. 1991;14:540\u20135.","journal-title":"Sleep"},{"key":"822_CR41","doi-asserted-by":"publisher","first-page":"475","DOI":"10.5664\/jcsm.2670","volume":"9","author":"BF Boeve","year":"2013","unstructured":"Boeve BF, Molano JR, Ferman TJ, Lin SC, Bieniek K, Tippmann-Peikert M, et al. Validation of the Mayo Sleep Questionnaire to screen for REM sleep behavior disorder in a community-based sample. J Clin Sleep Med. 2013;9:475\u201380.","journal-title":"J Clin Sleep Med"},{"issue":"2","key":"822_CR42","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1176\/jnp.12.2.233","volume":"12","author":"DI Kaufer","year":"2000","unstructured":"Kaufer DI, Cummings JL, Ketchel P, Smith V, MacMillan A, Shelley T, Lopez OL, DeKosky ST. Validation of the NPI-Q, a brief clinical form of the neuropsychiatric inventory. J Neuropsychiatry Clin Neurosci. 2000;12(2):233\u20139.","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"822_CR43","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1093\/geronj\/37.3.323","volume":"37","author":"RI Pfeffer","year":"1982","unstructured":"Pfeffer RI, Kurosaki TT, Harrah CH Jr., Chance JM, Filos S. Measurement of functional activities in older adults in the community. J Gerontol. 1982;37:323\u20139.","journal-title":"J Gerontol"},{"key":"822_CR44","first-page":"249","volume":"1","author":"JE Galvin","year":"2015","unstructured":"Galvin JE. The quick dementia rating system (QDRS): a rapid dementia staging tool. Alzheimer Dement. 2015;1:249\u201359.","journal-title":"Alzheimer Dement"},{"key":"822_CR45","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0240422","volume":"15","author":"JE Galvin","year":"2020","unstructured":"Galvin JE, Tolea MI, Chrisphonte S. Using a patient-reported outcome to improve detection of cognitive impairment and dementia: the patient version of the Quick Dementia Rating System (QDRS). PLoS ONE. 2020;15: e0240422.","journal-title":"PLoS ONE"},{"key":"822_CR46","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1111\/j.1532-5415.2005.53221.x","volume":"53","author":"ZS Nasreddine","year":"2005","unstructured":"Nasreddine ZS, Phillips NA, B\u00e9dirian V, Charbonneau S, Whitehead V, Collin I, Cummings JL, Chertkow H. The Montreal cognitive assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53:695\u20139.","journal-title":"J Am Geriatr Soc"},{"issue":"3","key":"822_CR47","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1076\/clin.13.3.348.1749","volume":"13","author":"AM Shapiro","year":"1999","unstructured":"Shapiro AM, Benedict RH, Schretlen D, Brandt J. Construct and concurrent validity of the Hopkins Verbal Learning Test-revised. Clin Neuropsychol. 1999;13(3):348\u201358.","journal-title":"Clin Neuropsychol"},{"key":"822_CR48","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0242233","volume":"15","author":"JE Galvin","year":"2020","unstructured":"Galvin JE, Tolea MI, Moore C, Chrisphonte S. The Number Symbol Coding Task: a brief measure of executive function to detect dementia and cognitive impairment. PLoS ONE. 2020;15: e0242233.","journal-title":"PLoS ONE"},{"key":"822_CR49","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.neuropsychologia.2014.01.017","volume":"56","author":"K Yokoi","year":"2014","unstructured":"Yokoi K, Nishio Y, Uchiyama M, Shimomura T, Iizuka O, Mori E. Hallucinators find meaning in noises: pareidolic illusions in dementia with Lewy bodies. Neuropsychologia. 2014;56:245\u201354.","journal-title":"Neuropsychologia"},{"key":"822_CR50","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/1477-7525-1-29","volume":"1","author":"RP Snaith","year":"2003","unstructured":"Snaith RP. The hospital anxiety and depression scale. Health Qual Life Outcomes. 2003;1:29.","journal-title":"Health Qual Life Outcomes"},{"key":"822_CR51","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.jalz.2011.03.008","volume":"7","author":"MS Albert","year":"2011","unstructured":"Albert MS, DeKosky ST, Dickson D, Dubois B, Feldman HH, Fox NC, et al. The diagnosis of mild cognitive impairment due to Alzheimer\u2019s disease: recommendations from the National Institute on Aging\u2013Alzheimer\u2019s association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimers Dement. 2011;7:270\u20139.","journal-title":"Alzheimers Dement"},{"key":"822_CR52","doi-asserted-by":"crossref","unstructured":"McKinney W. Data structures for statistical computing in python. In: Proceedings of the 9th python in science conference, vol. 445, SCIPY, Austin TX; 2010. p. 56\u201361.","DOI":"10.25080\/Majora-92bf1922-00a"},{"key":"822_CR53","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/s41592-019-0686-2","volume":"17","author":"P Virtanen","year":"2020","unstructured":"Virtanen P, Gommers R, Oliphant TE, Haberland M, Reddy T, Cournapeau D, et al. Scipy 1.0: fundamental algorithms for scientific computing in Python. Nat Methods. 2020;17:261\u201372.","journal-title":"Nat Methods"},{"key":"822_CR54","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1109\/MCSE.2007.55","volume":"9","author":"JD Hunter","year":"2007","unstructured":"Hunter JD. Matplotlib: a 2D graphics environment. Comput Sci Eng. 2007;9:90\u20135.","journal-title":"Comput Sci Eng"},{"key":"822_CR55","doi-asserted-by":"publisher","DOI":"10.1002\/trc2.70134","volume":"11","author":"JPM Kane","year":"2025","unstructured":"Kane JPM, Fitzpatrick RL, Betzhold S, Daly G, Kalfas E, kinchin I, et al. A common outcome set for trials in dementia with Lewy bodies (DLB COS). Alzheimers Dement (N Y). 2025;11: e70134.","journal-title":"Alzheimers Dement (N Y)"},{"key":"822_CR56","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1001\/jama.2014.13128","volume":"312","author":"AE McGlothlin","year":"2014","unstructured":"McGlothlin AE, Lewis RJ. Minimal clinically important difference: defining what really matters to patients. JAMA. 2014;312:1342\u20133.","journal-title":"JAMA"}],"container-title":["Neurology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40120-025-00822-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40120-025-00822-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40120-025-00822-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T12:03:39Z","timestamp":1763381019000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40120-025-00822-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,19]]},"references-count":56,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["822"],"URL":"https:\/\/doi.org\/10.1007\/s40120-025-00822-x","relation":{},"ISSN":["2193-8253","2193-6536"],"issn-type":[{"type":"print","value":"2193-8253"},{"type":"electronic","value":"2193-6536"}],"subject":[],"published":{"date-parts":[[2025,9,19]]},"assertion":[{"value":"25 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dr. Galvin is the creator of the Quick Dementia Rating System, Lewy Body Dementia Composite Risk Score, and the Number Symbol Coding Test. Dr. Galvin received research grants from the National Institutes of Health and is the Principal Investigator of the Lewy Body Dementia Association Research Center of Excellence at the University of Miami. Mr. Salcedo declares that he has no competing interests. The authors take full responsibility for the data and have the right to publish all data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"Dr. Galvin has approval with a waiver of consent from the Institutional Review Board at the University of Miami (reference no. 20200897) for a retrospective chart review. This study was performed in accordance with the Helsinki Declaration of 1964.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}